Skip to main content
Top
Published in: Digestive Diseases and Sciences 12/2006

01-12-2006 | Original Article

Hepatic Venous Pressure Gradient in Cirrhosis: Correlation with the Size of Varices, Bleeding, Ascites, and Child's Status

Authors: M. Wadhawan, S. Dubey, B. C. Sharma, S. K. Sarin, S. K. Sarin

Published in: Digestive Diseases and Sciences | Issue 12/2006

Login to get access

Abstract

The hepatic venous pressure gradient (HVPG) clearly reflects portal pressure in cirrhotic portal hypertension. Its relation with variceal bleeding has been well studied. We undertook to study the relation of HVPG to variceal size, Child's status, and etiology of cirrhosis. Patients with cirrhotic portal hypertension with esophageal varices underwent HVPG measurement as part of a prospective evaluation. One hundred seventy-six cirrhotics with varices (M:F, 140:36; mean age, 42.6 ± 13.4 years), 104 with CLD related to viral etiology, 40 with alcoholic liver disease, 26 cryptogenic with cirrhosis, and 6 with miscellaneous causes of CLD underwent HVPG measurement. The mean HVPG was lower in patients with small varices (n = 77; 14.6 ± 5.9 mm Hg) than in patients with large varices (n = 99; 19.2 ± 6.6 mm Hg; P < 0.01). In patients with large varices, the mean HVPG in bleeders (n = 37) was higher than in nonbleeders (n = 62) (21.7 ± 7.2 vs 17.9 ± 6.2 mm Hg; P < 0.01). The mean HVPG was significantly higher in Child's B (n = 97; 17.4 ± 6.9 mm Hg) and C (n = 56; 19.0 ± 5.7 mm Hg) compared to Child's A cirrhotics (n = 23; 12.2 ± 5.9 mm Hg; P < 0.01), and Child's C compared to Child's B cirrhotics (P = 0.05). HVPG was higher in alcoholic compared to nonalcoholic cirrhotics (20.8 ± 7.3 vs 16.4 ± 6.3 mm Hg; P < 0.05), but this was not significant in multivariate analysis. The HVPG was comparable between hepatitis B- and hepatitis C virus-related cirrhotics (P = 0.8). Cirrhotics with ascites had a higher HVPG than those without ascites (18.5 ± 5.6 vs 16.6 ± 7.6 mm Hg; P = 0.02). In multivariate analysis, only Child's status, size of varices, and variceal bleed predicted higher HVPG. HVPG is higher in cirrhotics with large varices and a history of bleed. There is a good correlation between HVPG and large varices, bleeder status, and ascites. A higher HVPG reflects more severe liver disease. The etiology of liver disease did not influence the portal pressure.
Literature
1.
go back to reference Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. (1985) Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 5:419–424PubMed Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. (1985) Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 5:419–424PubMed
2.
go back to reference Viallet A, Marleau D, Huet M, Martin F, Farley A, Villeneuve JP, Lavoie P (1975) Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient. Gastroenterology 69:1297–1300PubMed Viallet A, Marleau D, Huet M, Martin F, Farley A, Villeneuve JP, Lavoie P (1975) Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient. Gastroenterology 69:1297–1300PubMed
3.
go back to reference de Franchis R (2000) Updating consensus in portal hypertension. Report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 33:846–852CrossRefPubMed de Franchis R (2000) Updating consensus in portal hypertension. Report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 33:846–852CrossRefPubMed
4.
go back to reference Casado M, Bosch J, Garcia-Pagan JC, et al. (1998) Clinical events following transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 114:1296–1303CrossRefPubMed Casado M, Bosch J, Garcia-Pagan JC, et al. (1998) Clinical events following transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 114:1296–1303CrossRefPubMed
5.
go back to reference Groszmann RJ, Bosch J, Grace ND, et al. (1990) Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 99:1401–1407PubMed Groszmann RJ, Bosch J, Grace ND, et al. (1990) Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 99:1401–1407PubMed
6.
go back to reference Vorobioff J, Groszmann RJ, Picabea E, et al. (1996) Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology 111:701–709CrossRefPubMed Vorobioff J, Groszmann RJ, Picabea E, et al. (1996) Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology 111:701–709CrossRefPubMed
7.
go back to reference Escorsell A, Bordas JM, Castaneda B, Llach J, Garcia-Pagan JC, Rodes J, Bosch J (2000) Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension. Hepatology 31:1061–1067CrossRefPubMed Escorsell A, Bordas JM, Castaneda B, Llach J, Garcia-Pagan JC, Rodes J, Bosch J (2000) Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension. Hepatology 31:1061–1067CrossRefPubMed
8.
go back to reference Villanueva C, Minana J, Ortiz J, et al. (2001) Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 345:647–655CrossRefPubMed Villanueva C, Minana J, Ortiz J, et al. (2001) Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 345:647–655CrossRefPubMed
9.
go back to reference Rossle M, Siegerstetter V, Olschewski M, Ochs A, Berger E, Haag K (2001) How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Am J Gastroenterol 96:3379–3383PubMed Rossle M, Siegerstetter V, Olschewski M, Ochs A, Berger E, Haag K (2001) How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Am J Gastroenterol 96:3379–3383PubMed
10.
go back to reference Moitinho E, Escorsell A. Bandi JC, et al. (1999) Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117:626–631CrossRefPubMed Moitinho E, Escorsell A. Bandi JC, et al. (1999) Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117:626–631CrossRefPubMed
11.
go back to reference Sanyal AJ, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, McCashland T, North American Study for the Treatment of Refractory Ascites Group (2003) The North American Study for the Treatment of Refractory Ascites. Gastroenterology 124:634–641CrossRefPubMed Sanyal AJ, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, McCashland T, North American Study for the Treatment of Refractory Ascites Group (2003) The North American Study for the Treatment of Refractory Ascites. Gastroenterology 124:634–641CrossRefPubMed
12.
go back to reference The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices (1988) Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 319:983–989CrossRef The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices (1988) Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 319:983–989CrossRef
13.
go back to reference Bellis L, Castellacci R, Montagnese F, Festuccia F, Corvisieri P, Puoti C (2003) Hepatic venous pressure gradient determination in patients with hepatitis C virus-related and alcoholic cirrhosis. Eur J Gastroenterol Hepatol 15:1085–1089CrossRefPubMed Bellis L, Castellacci R, Montagnese F, Festuccia F, Corvisieri P, Puoti C (2003) Hepatic venous pressure gradient determination in patients with hepatitis C virus-related and alcoholic cirrhosis. Eur J Gastroenterol Hepatol 15:1085–1089CrossRefPubMed
14.
go back to reference Perello A, Escorsell A, Bru C, Gilabert R, Moitinho E, Garcia-Pagan JC, Bosch J (1999) Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology 30:1393–1397CrossRefPubMed Perello A, Escorsell A, Bru C, Gilabert R, Moitinho E, Garcia-Pagan JC, Bosch J (1999) Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology 30:1393–1397CrossRefPubMed
15.
go back to reference Valla D, Jiron MI, Poynard T, Lebrec D (1987) Failure of haemodynamic measurement to predict recurrent gastrointestinal bleeding incirrhotic patients receiving propranolol. J Hepatol 5:144–148CrossRefPubMed Valla D, Jiron MI, Poynard T, Lebrec D (1987) Failure of haemodynamic measurement to predict recurrent gastrointestinal bleeding incirrhotic patients receiving propranolol. J Hepatol 5:144–148CrossRefPubMed
16.
go back to reference Conn HO (1967) Ammonia tolerance in the diagnosis of esophageal varices: a comparison of the endoscopic, radiologic and biochemical techniques. J Lab Clin Med 70:442–451PubMed Conn HO (1967) Ammonia tolerance in the diagnosis of esophageal varices: a comparison of the endoscopic, radiologic and biochemical techniques. J Lab Clin Med 70:442–451PubMed
17.
go back to reference Lay CS, Tsai YT, Teg C, et al. (1997) Endoscopic variceal prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology 25:1346–1350CrossRefPubMed Lay CS, Tsai YT, Teg C, et al. (1997) Endoscopic variceal prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology 25:1346–1350CrossRefPubMed
18.
go back to reference D'Amico G, Pagliaro L, Bosch J (1999) Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 19:475–505PubMedCrossRef D'Amico G, Pagliaro L, Bosch J (1999) Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 19:475–505PubMedCrossRef
19.
go back to reference Merkel C, Marin R, Angeli P, Zanella P, Felder M, Bernardinello E, Cavallarin G, Bolognesi M, Donada C, Bellini B, Torboli P, Gatta A, Gruppo Triveneto per l'Ipertensione Portale (2004) A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology 127:476–484CrossRefPubMed Merkel C, Marin R, Angeli P, Zanella P, Felder M, Bernardinello E, Cavallarin G, Bolognesi M, Donada C, Bellini B, Torboli P, Gatta A, Gruppo Triveneto per l'Ipertensione Portale (2004) A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology 127:476–484CrossRefPubMed
20.
go back to reference Sarin SK, Sethi KK, Nanda R (1987) Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis. Gut 28:260–266PubMed Sarin SK, Sethi KK, Nanda R (1987) Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis. Gut 28:260–266PubMed
21.
go back to reference Thalheimer U, Mela M, Patch D, Burroughs AK (2004) Targeting portal pressure measurements; a critical reappraisal. Hepatology 39:286–290CrossRefPubMed Thalheimer U, Mela M, Patch D, Burroughs AK (2004) Targeting portal pressure measurements; a critical reappraisal. Hepatology 39:286–290CrossRefPubMed
22.
go back to reference Stanley AJ, Robinson I, Forrest EH, Jones AL, Hayes PC (1998) Hemodynamic parameters predicting variceal hemorrhage and survival in alcoholic cirrhosis. Q J Med 91:19–25 Stanley AJ, Robinson I, Forrest EH, Jones AL, Hayes PC (1998) Hemodynamic parameters predicting variceal hemorrhage and survival in alcoholic cirrhosis. Q J Med 91:19–25
23.
go back to reference Abraldes JG, Tararitino I, Turnes J, Garcia-Pagan JC, Rodes J, Bosch J (2003) Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 37:902–908CrossRefPubMed Abraldes JG, Tararitino I, Turnes J, Garcia-Pagan JC, Rodes J, Bosch J (2003) Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 37:902–908CrossRefPubMed
24.
go back to reference Burroughs AK, Groszman R, Bosch J, Grace N, Garcia-Tsao G, Patch D, Garcia-Pogan JCV, Dagher L (2002) Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C is hepatic venous pressure gradient a better end-point? Gut 50:425–427CrossRefPubMed Burroughs AK, Groszman R, Bosch J, Grace N, Garcia-Tsao G, Patch D, Garcia-Pogan JCV, Dagher L (2002) Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C is hepatic venous pressure gradient a better end-point? Gut 50:425–427CrossRefPubMed
Metadata
Title
Hepatic Venous Pressure Gradient in Cirrhosis: Correlation with the Size of Varices, Bleeding, Ascites, and Child's Status
Authors
M. Wadhawan
S. Dubey
B. C. Sharma
S. K. Sarin
S. K. Sarin
Publication date
01-12-2006
Published in
Digestive Diseases and Sciences / Issue 12/2006
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9310-2

Other articles of this Issue 12/2006

Digestive Diseases and Sciences 12/2006 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.